Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. 9-796-181
Published by: Harvard Business Publishing
Originally published in: 1996
Version: 18 February 1998
Length: 19 pages
Data source: Field research

Abstract

Depicts a leading Indian pharmaceutical company reacting to changes in its industry by trying to reposition along several dimensions from developing markets to developed ones, from buck drugs toward pharmaceuticals in dosage forms and from reverse-engineering products developed by others toward original research.; To permit a systematic discussion of the pros and cons of scope expansion in response to changes in industry structure.

About

Abstract

Depicts a leading Indian pharmaceutical company reacting to changes in its industry by trying to reposition along several dimensions from developing markets to developed ones, from buck drugs toward pharmaceuticals in dosage forms and from reverse-engineering products developed by others toward original research.; To permit a systematic discussion of the pros and cons of scope expansion in response to changes in industry structure.

Related